Conditioning & Open-Label Placebo (COLP) for Opioid Management in Intensive Inpatient Rehabilitation

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
The use of the conditioning open-label placebo (COLP) paradigm will be studied as a dose extension method to lower opioid dosage in patients with spinal cord injury, polytrauma, and burn injury. The goal is to provide the same level of pain relief with a reduced opioid intake to diminish side effects as well as the risk of addiction associated with opioid treatment.
Epistemonikos ID: a222653f2a3a55bf7e799b69bb035aaf0f357368
First added on: May 13, 2024